Canopy Growth Operating Income Over Time
| CGC Stock | USD 1.17 0.02 1.74% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Canopy Growth Performance and Canopy Growth Correlation. Will Pharmaceuticals sector continue expanding? Could Canopy diversify its offerings? Factors like these will boost the valuation of Canopy Growth. Projected growth potential of Canopy fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Canopy Growth data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.36) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Canopy Growth Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Canopy Growth's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Canopy Growth's market price to deviate significantly from intrinsic value.
It's important to distinguish between Canopy Growth's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Canopy Growth should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Canopy Growth's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Canopy Growth Corp and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COR | 77.9 M | 1.3 B | 989 M | 1.2 B | 1.3 B | 1.7 B | 2 B | 1.7 B | 1.9 B | 2 B | 2.7 B | 2.8 B | 2.4 B | 3 B | 3.6 B | 4.2 B | 4.4 B |
| REGN | (3.3 M) | (205.2 M) | 457.7 M | 760 M | 838.4 M | 1.3 B | 1.3 B | 2.1 B | 2.5 B | 2.2 B | 3.6 B | 8.9 B | 5.4 B | 4 B | 4 B | 3.6 B | 3.8 B |
| IDXX | 2.6 M | 236.2 M | 262.6 M | 266.8 M | 260.3 M | 299.9 M | 350.2 M | 413 M | 491.3 M | 552.8 M | 694.5 M | 932 M | 898.8 M | 1.1 B | 1.1 B | 1.4 B | 1.4 B |
| HLN | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 1.6 B | 1.6 B | 1.8 B | 2 B | 2.2 B | 2.5 B | 1.9 B |
| CI | (854.9 M) | 1.9 B | 2.9 B | 32.4 B | 11.6 B | 12.4 B | 3.1 B | 3.9 B | 4.2 B | 8.1 B | 8.2 B | 7.9 B | 8.4 B | 8.5 B | 9.4 B | 9.1 B | 9.6 B |
| ELV | 11.1 B | 4.5 B | 4.4 B | 4.7 B | 5.1 B | 5.4 B | 5.4 B | 5 B | 5.8 B | 6.7 B | 7.7 B | 8.9 B | 8.5 B | 8.7 B | 8.9 B | 8.1 B | 6.8 B |
| BDX | 137.7 M | 1.6 B | 1.3 B | 1.6 B | 1.1 B | 1.4 B | 1.5 B | 1.5 B | 1.8 B | 912 M | 2.2 B | 2.3 B | 2.1 B | 2.4 B | 2.6 B | 3 B | 3.1 B |
| ELAN | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 283.2 M | 142.4 M | 313.8 M | 370 M | (76.8 M) | 304 M | 384 M | 326 M | 251 M | 288.6 M | 253.3 M |
| ARGX | (4.7 M) | (4.7 M) | (13.3 M) | (8.6 M) | (13.1 M) | (17.1 M) | (22.5 M) | (27.5 M) | (93.6 M) | (198.9 M) | (477.6 M) | (348.7 M) | (720.3 M) | (425 M) | (21.7 M) | (19.5 M) | (20.5 M) |
| TAK | 171.4 B | 265 B | 122.5 B | 139.3 B | (129.3 B) | 130.8 B | 155.9 B | 241.8 B | 205 B | 100.4 B | 509.3 B | 460.8 B | 490.5 B | 214.1 B | 342.6 B | 308.3 B | 226.9 B |
Canopy Growth Corp and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Income description
Operating Income is the amount of profit realized from Canopy Growth Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Canopy Growth Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Canopy Growth Corp | CGC |
| Classification | Cannabis |
| Business Address | 1 Hershey Drive, |
| Exchange | NASDAQ Exchange |
USD 1.17
Check out Canopy Growth Performance and Canopy Growth Correlation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Canopy Growth technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.